These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22211921)

  • 1. Adipocytokine zinc α2 glycoprotein (ZAG) as a novel urinary biomarker for normo-albuminuric diabetic nephropathy.
    Lim SC; Liying DQ; Toy WC; Wong M; Yeoh LY; Tan C; Lau D; Tan C; Subramaniam T; Sum CF
    Diabet Med; 2012 Jul; 29(7):945-9. PubMed ID: 22211921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
    J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
    Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
    J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy.
    Fukuda A; Minakawa A; Kikuchi M; Sato Y; Nagatomo M; Nakamura S; Mizoguchi T; Fukunaga N; Shibata H; Naik AS; Wiggins RC; Fujimoto S
    Sci Rep; 2020 Oct; 10(1):18209. PubMed ID: 33097787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
    Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
    J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative diagnostic utility of different urinary biomarkers during pre-albuminuric stages of non-hypertensive type 2 diabetic nephropathy.
    Mahapatra HS; Kulshreshtha B; Goyal P; Chitkara A; Kumari A; Arora A; Sekhar V; Gupta YP
    Indian J Med Res; 2022 Jul; 156(1):46-55. PubMed ID: 36510897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. URINARY EXCRETION OF ALPHA-ACTININ-4 AND TIGHT JUNCTION PROTEIN 1 IN PATIENTS WITH TYPE 2 DIABETES AND DIFFERENT PATTERNS OF CHRONIC KIDNEY DISEASE.
    Korbut A; Romanov V; Klimontov V
    Georgian Med News; 2024 Mar; (348):72-77. PubMed ID: 38807395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the urinary kidney injury molecule-1 levels in patients with diabetic nephropathy.
    Kin Tekce B; Tekce H; Aktas G; Sit M
    Clin Invest Med; 2014 Dec; 37(6):E377-83. PubMed ID: 25618270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic identification of urinary biomarkers of diabetic nephropathy.
    Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
    Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus.
    Boronat M; García-Cantón C; Quevedo V; Lorenzo DL; López-Ríos L; Batista F; Riaño M; Saavedra P; Checa MD
    Ren Fail; 2014 Mar; 36(2):166-70. PubMed ID: 24059817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney outcomes and all-cause mortality in people with type 2 diabetes exhibiting non-albuminuric kidney insufficiency.
    Yamamoto Y; Hanai K; Mori T; Yokoyama Y; Yoshida N; Murata H; Shinozaki T; Babazono T
    Diabetologia; 2022 Jan; 65(1):234-245. PubMed ID: 34739552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albuminuric and non-albuminuric reduced eGFR phenotypes in youth with type 1 diabetes: Factors associated with cardiometabolic risk.
    Di Bonito P; Mozzillo E; Rosanio FM; Maltoni G; Piona CA; Franceschi R; Ripoli C; Ricciardi MR; Tornese G; Arnaldi C; Iovane B; Iafusco D; Zanfardino A; Suprani T; Savastio S; Cherubini V; Tiberi V; Piccinno E; Schiaffini R; Delvecchio M; Casertano A; Maffeis C; Franzese A;
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2033-2041. PubMed ID: 34083127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminura.
    McAuliffe AV; Fisher EJ; McLennan SV; Yue DK; Turtle JR
    Diabet Med; 1996 Aug; 13(8):758-63. PubMed ID: 8862953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial.
    Kato S; Maruyama S; Makino H; Wada J; Ogawa D; Uzu T; Araki H; Koya D; Kanasaki K; Oiso Y; Goto M; Nishiyama A; Kobori H; Imai E; Ando M; Matsuo S
    Clin Exp Nephrol; 2015 Dec; 19(6):1098-106. PubMed ID: 25795029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of macro- and microvascular complications in patients with type 2 diabetes and kidney disease with or without albuminuria in a single Chinese Diabetes Centre.
    Wu D; Xuan Y; Ruan Y; Feng X; Zhu Y; Jia C; Liu J; Li H; Li L; Dong X
    Diab Vasc Dis Res; 2016 Jan; 13(1):21-30. PubMed ID: 26499917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A; Bdeer Sel-A; El-Sokkary RH
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
    Sharma K; Lee S; Han S; Lee S; Francos B; McCue P; Wassell R; Shaw MA; RamachandraRao SP
    Proteomics; 2005 Jul; 5(10):2648-55. PubMed ID: 15984045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary Haptoglobin Predicts Rapid Renal Function Decline in Asians With Type 2 Diabetes and Early Kidney Disease.
    Liu JJ; Liu S; Wong MD; Gurung RL; Lim SC
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3794-3802. PubMed ID: 27459536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
    Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.